NSC |
Compound |
Enrichment |
Correlation |
NSC 753221 |
3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline |
0.011544784012433 |
0.19871062 |
NSC 87086 |
Null |
0.011544784012433 |
-0.13325237 |
NSC 154751 |
Urea, N'-(5,6-dichloro-1H-benzimidazol-2-yl)-N,N-dimethyl- |
0.0115447840124334 |
0.34590257 |
NSC 287459 |
Cytarabine AY |
0.0115447840124334 |
0.27058875 |
NSC 321206 |
Null |
0.0123744972338278 |
0.50067678 |
NSC 332837 |
Carbamothioic acid, dimethyl-, S-[2-(2,6-dichlorophenyl)-1-oxo-1H-inden-3-yl] ester |
0.0123744972338278 |
0.66809352 |
NSC 363143 |
Stannane, dichlorodiphenyl-, compd. with 1,4,7,10,13,16-hexaoxacyclooctadecane (1:1) |
0.0123744972338278 |
0.68897995 |
NSC 603086 |
2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- |
0.0123744972338278 |
0.7300618 |
NSC 603555 |
2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride |
0.0123744972338278 |
0.72877887 |
NSC 619102 |
4-Methoxy-1,5-benzothiazepine-1,1-dioxide |
0.0123744972338278 |
0.58168342 |